In its April 2019 NEWSletter, the Patented Medicine Prices Review Board (PMPRB) announced that the Steering Committee on Guidelines Modernization would hold its final meeting on May 13, 2019, to discuss both a draft report of its deliberations and the Working Group’s final report (released March 6, 2019). Once the Steering Committee’s report has been finalized and the regulatory amendments have been published in Part II of the Canada Gazette (expected this spring), the PMPRB will release its draft Guidelines for public consultation.
Related Publications & Articles
-
Government of Canada announces first pharmacare agreements
The Minister of Health recently announced the first of these bilateral agreements with Manitoba ($219 million over four years), British Columbia ($670 million over four years) and Prince Edward Island...Read More -
PMPRB announces Anie Perrault as acting Chairperson and releases latest expenditure report on private drug plan costs and utilization
On March 6, 2025, the Patented Medicine Prices Review Board announced that Thomas Digby stepped down from his role as Chairperson of the PMPRB. Vice-Chairperson Anie Perrault is now serving as acting ...Read More -
CDA update: new five-year strategic plan and position statement on using AI in health technology assessments
On April 15, 2025 Canada’s Drug Agency (CDA) released its new five-year strategic plan, Insight to Impact 2025-2030.Read More